The Biologic Association's mission to foster and convene a collaboration for shared and coordinated efforts to speak with a unified voice in the musculoskeletal biologics environment, advocating for the responsible use of biologics in clinical practice, spearheading standards development, and assessing and reporting on the safety and efficacy of biologic interventions.
The Biologic Association Website
The purpose of Biologic Association’s site is to create a medical education community that fosters collaboration and offers a pool of expert clinical references for access by all members. This site is being established to address the needs of physicians so that there is a single destination site to provide educational material on an on-going basis as the underlying science evolves.
Our goal is global. The Biologic Association provides educational assistance worldwide for physicians and healthcare professionals. Our platform allows our members to deepen their clinical knowledge, gain insight into medical options, and stay current on medical and scientific research and findings, patient care and the treatments.
The Biologic Association website will provide educational access across a variety of platforms:
This section will provide the most up to date information on the safety and efficacy of biologic interventions.
Videos: examples include Adipose harvest, PRP, BMAC (posterior and Iliac crest)
Breakthrough technologies and clinical solutions will be covered. While still lacking comprehensive clinical support this area is intended to bring to the forefront leading edge practices that might evolve into new standards of care.
CME will be developed and provided in the future based on scientifically supported information. Stay tuned.
Biologic Association Website Policy
The Biologics Association will host an independent website platform that is entirely separate from any of the participating Organizations’ website platforms. This website will be a central hub to post Association business, proceedings and activities and will also be a trusted source for physicians to attain vetted and graded educational material, current best practices and procedures. In order to minimize the potential bias of industry, and physician relationships with industry, there will be NO company logos, advertising or references posted on the Biologics Association educational website at any time. Industry participation will be in a separate, bifurcated area of the site. Additionally, all members of the website oversite committee (WOC) will be subject to a rigorous Conflict of Interest review by the Board of Directors before becoming an official voting member of the WOC.
Website Oversight Committee
The website oversight committee (WOC) will be composed of one of the three official delegates from each of the Regular Member Organizations, a committee chairman, a Medsite representative (to provide a business and site management perspective), and additional working members. The committee will always have an odd number of members, but must have at least 5 members. Voting for website content will follow the protocol established in the bylaws, however voting can be accomplished within the committee and does not have to have a formal Association Board vote. The WOC will be responsible for grading and vetting all data, scientific and procedural material that is posted on the website, along with vetting all corporate advertising for minimum criteria for the separate corporate area of the website.
All material posted on the website must have unanimous agreement of the voting Regular Member Organization WOC delegates and achieve a majority vote of all committee members before any content is posted. All web content will be vetted by the following procedure before voting can commence.
Scientific Content Review Process for Main Biologics Alliance website content posting
All educational content will be reviewed by the WOC for minimum criteria prior to posting.
Minimum content requirements (must have at least one of the following requirements):
• Content has already been presented at one of the Biologics Association Member Organization’s national meeting. Content will be considered as peer reviewed.
• Content that has already been published in a PubMed indexed, peer-reviewed journal.
• There are no identified ethical or regulatory concerns of the described technique, device application, or biologic.
• There is no identified conflict of interest by the presenter, Biologics Association or the WOC.
A minimum of three (3) WOC members will review each piece of educational content for the minimum criteria, and will then preliminarily vote to allow or reject the media. If accepted, the material will then undergo a formal vote by the WOC before posting on the website.
Website Oversight committee
• David Flanigan, MD (Chair)
• Rick Kovach (Medsite, LLC)
• Jack Farr, MD (Lead, Corporate site)
• Adam Anz, MD (Lead, Educational site)
• Seth Sherman, MD
• Adam Yanke, MD
• Voting members from AOSSM, AANA, ICRS, ON
• Scott Rodeo, MD (AOSSM)
• Brian Cole, MD, MBA (AANA)
• Christian Lattermann, MD (ICRS)